HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.

AbstractBACKGROUND:
Financial capacity is often one of the first instrumental activities of daily living to be affected in cognitively normal (CN) older adults who later progress to amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia.
OBJECTIVE:
The objective of this study was to investigate the association between financial capacity and regional cerebral tau.
METHODS:
Cross-sectional financial capacity was assessed using the Financial Capacity Instrument -Short Form (FCI-SF) in 410 CN, 199 MCI, and 61 AD dementia participants who underwent flortaucipir tau positron emission tomography from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Linear regression models with backward elimination were used with FCI-SF total score as the dependent variable and regional tau and tau-amyloid interaction as predictors of interest in separate analyses. Education, age, sex, Rey Auditory Verbal Learning Test Total Learning, and Trail Making Test B were used as covariates.
RESULTS:
Significant associations were found between FCI-SF and tau regions (entorhinal: p < 0.001; inferior temporal: p < 0.001; dorsolateral prefrontal: p = 0.01; posterior cingulate: p = 0.03; precuneus: p < 0.001; and supramarginal gyrus: p = 0.005) across all participants. For the tau-amyloid interaction, significant associations were found in four regions (amyloid and dorsolateral prefrontal tau interaction: p = 0.005; amyloid and posterior cingulate tau interaction: p = 0.005; amyloid and precuneus tau interaction: p < 0.001; and amyloid and supramarginal tau interaction: p = 0.002).
CONCLUSION:
Greater regional tau burden was modestly associated with financial capacity impairment in early-stage AD. Extending this work with longitudinal analyses will further illustrate the utility of such assessments in detecting clinically meaningful decline, which may aid clinical trials of early-stage AD.
AuthorsChristopher Gonzalez, Nicole S Tommasi, Danielle Briggs, Michael J Properzi, Rebecca E Amariglio, Gad A Marshall, Alzheimer’s Disease Neuroimaging Initiative
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 79 Issue 3 Pg. 1133-1142 ( 2021) ISSN: 1875-8908 [Electronic] Netherlands
PMID33386806 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • tau Proteins
Topics
  • Activities of Daily Living (psychology)
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (diagnosis, pathology, psychology)
  • Brain (diagnostic imaging, pathology)
  • Case-Control Studies
  • Cognitive Dysfunction (diagnosis, pathology, psychology)
  • Cross-Sectional Studies
  • Female
  • Financial Management
  • Humans
  • Linear Models
  • Male
  • Mental Competency (psychology)
  • Middle Aged
  • Positron-Emission Tomography
  • Severity of Illness Index
  • tau Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: